• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of core outcome sets for the assessment of adverse events between treatments of cancer immunotherapy

Research Project

Project/Area Number 24K13334
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 58010:Medical management and medical sociology-related
Research InstitutionTohoku University

Principal Investigator

山口 拓洋  東北大学, 医学系研究科, 教授 (50313101)

Co-Investigator(Kenkyū-buntansha) 川口 崇  東京薬科大学, 薬学部, 教授 (60548486)
Project Period (FY) 2024-04-01 – 2029-03-31
Project Status Granted (Fiscal Year 2024)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2028: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2027: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2026: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2025: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2024: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Keywords患者報告アウトカム / 有害事象評価 / コアアウトカムセット / がん免疫療法 / PRO-CTCAE
Outline of Research at the Start

本研究では、がん治療の主流となりつつある免疫療法に焦点を当て、日常診療で評価するPRO-CTCAE項目のコアアウトカムセットを策定し、有害事象の詳細および全般の負担度の両側面から治療間比較可能となるレジストリを構築することを目的とする。

URL: 

Published: 2024-04-05   Modified: 2024-06-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi